The ALK gene is often fused with EML4 gene in NSCLC, leading to continuous expression of ALK and the activation of downstream PI3K/Akt/MAPK signal pathway and occurrence of tumors [56, 57]. This evidence concerns the gene ALK and non-small cell lung carcinoma.